123 related articles for article (PubMed ID: 32906146)
1. Designing and Interpreting Coronavirus Disease 2019 (COVID-19) Diagnostics: Mathematics, Visual Logistics, and Low Prevalence.
Kost GJ
Arch Pathol Lab Med; 2021 Mar; 145(3):291-307. PubMed ID: 32906146
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Increasing Disease Prevalence, False Omissions, and Diagnostic Uncertainty on Coronavirus Disease 2019 (COVID-19) Test Performance.
Kost GJ
Arch Pathol Lab Med; 2021 Jul; 145(7):797-813. PubMed ID: 33684204
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Strategies for Endemic Coronavirus Disease 2019 (COVID-19).
Kost GJ
Arch Pathol Lab Med; 2022 Jan; 146(1):16-25. PubMed ID: 34551070
[TBL] [Abstract][Full Text] [Related]
4. Setting minimum clinical performance specifications for tests based on disease prevalence and minimum acceptable positive and negative predictive values: Practical considerations applied to COVID-19 testing.
Loh TP; Lord SJ; Bell K; Bohn MK; Lim CY; Markus C; Fares Taie H; Adeli K; Lippi G; Sandberg S; Horvath A
Clin Biochem; 2021 Feb; 88():18-22. PubMed ID: 33227233
[TBL] [Abstract][Full Text] [Related]
5. Specificity and positive predictive value of SARS-CoV-2 nucleic acid amplification testing in a low-prevalence setting.
Skittrall JP; Wilson M; Smielewska AA; Parmar S; Fortune MD; Sparkes D; Curran MD; Zhang H; Jalal H
Clin Microbiol Infect; 2021 Mar; 27(3):469.e9-469.e15. PubMed ID: 33068757
[TBL] [Abstract][Full Text] [Related]
6. The Coronavirus Disease 2019 Spatial Care Path: Home, Community, and Emergency Diagnostic Portals.
Kost GJ
Diagnostics (Basel); 2022 May; 12(5):. PubMed ID: 35626375
[TBL] [Abstract][Full Text] [Related]
7. Point-of-care testing for the detection of SARS-CoV-2: a systematic review and meta-analysis.
Yoon SH; Yang S; Cho H; Eun S; Koo CM; Kim MK
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):503-517. PubMed ID: 33506942
[TBL] [Abstract][Full Text] [Related]
8. Rapid coronavirus tests: a guide for the perplexed.
Guglielmi G
Nature; 2021 Feb; 590(7845):202-205. PubMed ID: 33564189
[No Abstract] [Full Text] [Related]
9. Experience With False-Positive Test Results on the TaqPath Real-Time Reverse Transcription-Polymerase Chain Reaction Coronavirus Disease 2019 (COVID-19) Testing Platform.
Lin L; Carlquist J; Sinclair W; Hall T; Lopansri BK; Bennett ST
Arch Pathol Lab Med; 2021 Mar; 145(3):259-261. PubMed ID: 33237991
[No Abstract] [Full Text] [Related]
10. Analytical and Clinical Analysis of Two Automated Anti-SARS-CoV-2 Immunoassays in Pre-Pandemic and Pandemic Patient Populations.
Yang J; Pederson EC; Hamilton C; Neibauer T; Robyak K; McGhee P; Speicher T; Zhu Y
J Appl Lab Med; 2021 Mar; 6(2):441-450. PubMed ID: 33152084
[TBL] [Abstract][Full Text] [Related]
11. Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points to IgM as the Achilles heel.
Mboumba Bouassa RS; Péré H; Tonen-Wolyec S; Longo JD; Moussa S; Mbopi-Keou FX; Mossoro-Kpinde CD; Grésenguet G; Veyer D; Bélec L
J Med Virol; 2021 Apr; 93(4):2196-2203. PubMed ID: 33107601
[TBL] [Abstract][Full Text] [Related]
12. Isothermal SARS-CoV-2 Diagnostics: Tools for Enabling Distributed Pandemic Testing as a Means of Supporting Safe Reopenings.
Khan P; Aufdembrink LM; Engelhart AE
ACS Synth Biol; 2020 Nov; 9(11):2861-2880. PubMed ID: 32966744
[TBL] [Abstract][Full Text] [Related]
13. Predictors of negative first SARS-CoV-2 RT-PCR despite final diagnosis of COVID-19 and association with outcome.
Lascarrou JB; Colin G; Le Thuaut A; Serck N; Ohana M; Sauneuf B; Geri G; Mesland JB; Ribeyre G; Hussenet C; Boureau AS; Gille T
Sci Rep; 2021 Jan; 11(1):2388. PubMed ID: 33504923
[TBL] [Abstract][Full Text] [Related]
14. Interpreting SARS-CoV-2 Test Results.
Coffey KC; Diekema DJ; Morgan DJ
JAMA; 2021 Oct; 326(15):1528-1529. PubMed ID: 34533581
[No Abstract] [Full Text] [Related]
15. Simple Questionnaires to Improve Pooling Strategies for SARS-CoV-2 Laboratory Testing.
Schneitler S; Jung P; Bub F; Alhussein F; Benthien S; Berger FK; Berkó-Göttel B; Eisenbeis J; Hahn D; Halfmann A; Last K; Linxweiler M; Lohse S; Papan C; Pfuhl T; Rissland J; Roth S; Schlotthauer U; Utzinger J; Smola S; Gärtner BC; Becker SL
Ann Glob Health; 2020 Nov; 86(1):148. PubMed ID: 33262937
[TBL] [Abstract][Full Text] [Related]
16. Implementation of Reverse Transcriptase PCR Testing for Severe Acute Respiratory Syndrome Coronavirus 2 under the US Food and Drug Administration Emergency Use Authorization.
Lefferts JA; Allen SF; Steinmetz HB; Tsongalis GJ
Clin Chem; 2021 Jan; 67(2):434-435. PubMed ID: 33315063
[No Abstract] [Full Text] [Related]
17. Rapid Implementation of Severe Acute Respiratory Syndrome Coronavirus 2 Emergency Use Authorization RT-PCR Testing and Experience at an Academic Medical Institution.
Velu P; Craney A; Ruggiero P; Sipley J; Cong L; Hissong EM; Loda M; Westblade LF; Cushing M; Rennert H
J Mol Diagn; 2021 Feb; 23(2):149-158. PubMed ID: 33285285
[TBL] [Abstract][Full Text] [Related]
18. Guidance for the design and reporting of studies evaluating the clinical performance of tests for present or past SARS-CoV-2 infection.
Doust JA; Bell KJL; Leeflang MMG; Dinnes J; Lord SJ; Mallett S; van de Wijgert JHHM; Sandberg S; Adeli K; Deeks JJ; Bossuyt PM; Horvath AR
BMJ; 2021 Mar; 372():n568. PubMed ID: 33782084
[No Abstract] [Full Text] [Related]
19. Discrimination of False Negative Results in RT-PCR Detection of SARS-CoV-2 RNAs in Clinical Specimens by Using an Internal Reference.
Zhang Y; Wang C; Han M; Ye J; Gao Y; Liu Z; He T; Li T; Xu M; Zhou L; Zou G; Lu M; Zhang Z
Virol Sin; 2020 Dec; 35(6):758-767. PubMed ID: 32749593
[TBL] [Abstract][Full Text] [Related]
20. Current Status of Diagnostic Testing for SARS-CoV-2 Infection and Future Developments: A Review.
Gao J; Quan L
Med Sci Monit; 2020 Dec; 26():e928552. PubMed ID: 33332288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
